A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

NCT05911828 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncomplicated Malaria
Asymptomatic Condition
Falciparum Malaria

Interventions

DRUG: ZY19489 + Ferroquine (FQ)
DRUG: Placebo

Sponsor

Zydus Lifesciences Limited